<DOC>
	<DOCNO>NCT01774357</DOCNO>
	<brief_summary>This observational registry study aim collect data efficacy safety single chamber Biotronik DX system enhance atrial diagnostics . The minimal follow-up period 24 month . All analyse data do post-hoc ; study intend confirm pre-specified hypothesis .</brief_summary>
	<brief_title>Management Detection Atrial Tachyarrhythmias Patients Implanted With BIOTRONIK DX Systems</brief_title>
	<detailed_description>Enrollment ( E0 ) Timing : • The enrollment ( date patient write informed consent ) start implantation BIOTRONIK Lumax 540 VR-T DX ICD Linoxsmart S DX successor single chamber DX system accord current guideline ( primary secondary prevention ) later 90 day implantation . Procedures : - Check inclusion exclusion criterion - Patient information write informed consent process - Assignment unique study code - ICD interrogation ( re-programming necessary ) - HMSC registration ( recommend ) - Investigator assessment : appropriate atrial sense Documentation ( note : available recent assessment record within six month prior hospital discharge shall consider ) : - Medical History : - Demographic data - General history cardiovascular disease - Etiology underlying heart disease - Cardiac event symptom - Documented supraventricular arrhythmia prior implantation - Device Interrogation - Date , home monitoring function , MRI scan - AF history : - type ( none , paroxysmal , persistent , permanent ) - date first diagnosis ( applicable ) - EHRA classification ( applicable ) - AF burden ( available ) - CHA2DS2-VASc - Risk factor comorbidities : - thyroid dysfunction - diabetes mellitus - COPD - sleep apnea - chronic renal disease - History thromboembolic event stroke - Physical Examination : - Vital sign ( SBP , DBP , height , body weight , BMI ) - Current medication ( substance class ) - Heart failure index - NYHA classification - BNP NT-proBNP ( determine routine clinical practice ) - LVEF ( optional ; echocardiography prefer , method accept echo available ) - ECG parameter ( 12 lead ECG ; optional ) - RR , PQ , QT intervals - QRS width - rhythm disorder - clinical finding , morphology - Implantation : - Indication ( primary prevention , secondary prevention ) - Type procedure ( first implantation / replacement ) - RV lead : - Dislodgement / reposition implantation ? - Sufficient amplitude ( Atrial ; Ventricular ) threshold ( Ventricular ) - Other clinical complication / implantation ? - Final lead position discharge ( apical , septal , ) - Atrial dipole ( without atrial wall contact rest ) - Ease implantation assess investigator - An extended questionnaire include detailed information implantation procedure , technique initial measurement request optional documentation data available Follow-up Y1 Y2 Timing : • 12 24 month ( +/-2 month ) enrollment respectively Procedures : - ICD interrogation / function check-up re-programming necessary - Programmer download data yet submit BIOTRONIK accord current work instruction - Investigator assessment : appropriate atrial sense Documentation ( note : available recent assessment record current precede visit shall consider ) : - Physical Examination : - Vital sign ( SBP , DBP , height , body weight , BMI ) - Current medication ( substance class ) - Heart Failure index : - NYHA classification - BNP NT-proBNP ( determine routine clinical practice ) - LVEF ( optional ; echocardiography prefer , method accept echo available ) - ECG parameter ( 12 lead ECG ; optional ) : - RR , PQ , QT intervals - QRS width - rhythm disorder - clinical finding , morphology - Device Interrogation - Date , home monitoring function , MRI scan Event base documentation - New-onset worsening AF - AF intervention - Worsening heart failure - Shock episode - Thromboembolic event ( CVA , TIA , PAE ) - Continuous surveillance / reporting ( serious ) adverse event / ( serious ) adverse device effect</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>Indication implantation single chamber ICD ( primary secondary prevention ) accord current guideline Implanted BIOTRONIK Lumax 540 VRT DX ICD Linoxsmart S DX successor single chamber DX system within 90 day prior enrollment Written inform consent , willingness ability comply protocol Age &lt; 18 year Any limitation contractual capability Female patient pregnant breast feed plan pregnancy course study Known active malignant disease recover malignant disease within 2 year prior enrollment Simultaneous participation another study Life expectancy &lt; 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>